Frisby Research
Client Login
Back to public dashboard

Neurodegeneration Biotech Companies and Upcoming Catalysts

Public company snapshots and catalyst previews organized by sector.

Public Company List

TickerCompanyLead AssetIndicationStageNext Catalyst
BIVIBioVie IncNE3107Parkinson DiseasePhase 32026-08
IGCIGC Pharma IncIntellectual Property and PatentsAlzheimerApproved2026-08
KPRXKiora Pharmaceuticals IncKIO-301Late-stage Retinitis Pigmentosa (ABACUS-2) NCT06628947Phase 22026-11
ALZNAlzamend Neuro IncAL001Alzheimer's Disease | Healthy Non-elderly and Elderly AdultsPivotal2026-12
SXTP60 Degrees Pharmaceuticals IncCELGOSIVIRn/aApproved2026-12-08
ATNMActinium Pharmaceuticals IncVideo Galleryn/aPhase 32026-12-31
TSHATaysha Gene TherapiesTSHA-102Rett SyndromePhase 32027-03-12
TELOTelomir Pharmaceuticals IncTargeting Metal-Dependent Epigenetic Dysregulationn/an/a2027-05
CNSPCns Pharmaceuticals IncLevodopa-carbidopa intestinal gelAdvanced Parkinson's DiseasePhase 32027-06
ACXPAcurx Pharmaceuticals IncIbezapolstatClostridium Difficile InfectionPhase 22027-09-29
ADILAdial Pharmaceuticals IncAD04AD04 Planned Phase 3 Trial Continue ReadingRegistrationalCorporate Update
BRTXBioRestorative Therapies IncCurrent Trialsstudy ID numberPhase 2Data Readout
CTXRCitius Pharmaceuticals IncLYMPHIR TMn/aApprovedn/a
CURXCuranex Pharmaceuticals IncTraditional Use in Chinan/aPreclinicaln/a
INMBINmune Bio IncXPro1595Alzheimer DiseasePhase 2Data Readout
JUNSJupiter Neurosciences IncAtogepantEpisodic MigrainePhase 3n/a
LGVNLongeveron IncAllogeneic MSCMild Alzheimer's DiseasePhase 2Corporate Update
NBYNovabay Pharmaceuticals IncNVC-422, 0.2%Urinary Catheter Blockage and EncrustationPhase 2n/a
PCSAProcessa Pharmaceuticals IncEnrollmentmarketing by a regulatory agencyApprovedData Readout
PHIOPhio Pharmaceuticals CorpDiscoveryn/aPreclinicaln/a
QNRXQuoin Pharmaceuticals Ltd ADRNetherton Syndromen/aApprovedIND Filing
VIGLVigil NeuroscienceVGL101ALSPPhase 2n/a

Upcoming Catalysts

Company Ticker Catalyst Timing Asset Confidence
BioVie Inc BIVI Clinical Trial Completion 2026-08 NE3107 Low
IGC Pharma Inc IGC Clinical Trial Completion 2026-08 IGC-AD1-Active Low
Kiora Pharmaceuticals Inc KPRX Clinical Trial Completion 2026-11 KIO-104 Low
Alzamend Neuro Inc ALZN Clinical Trial Completion 2026-12 AL001 Low
60 Degrees Pharmaceuticals Inc SXTP Clinical Trial Completion 2026-12-08 mRNA-1645-eODGT8 Low
Actinium Pharmaceuticals Inc ATNM Clinical Trial Completion 2026-12-31 Actinium Ac 225 DOTATATE RYZ101 Low
60 Degrees Pharmaceuticals Inc SXTP Clinical Trial Completion 2026-12-31 Whole-Body Electrical Muscle Stimulation (WB-EMS) Training Low
60 Degrees Pharmaceuticals Inc SXTP Clinical Trial Completion 2027-04-01 NPX372 Low
Telomir Pharmaceuticals Inc TELO Clinical Trial Completion 2027-05 Zn-Telomir Low
Cns Pharmaceuticals Inc CNSP Clinical Trial Completion 2027-06 Xevinapant Low
Acurx Pharmaceuticals Inc ACXP Presentation October 2025 n/a Low
Acurx Pharmaceuticals Inc ACXP Data Readout Timing not specified n/a Low
Adial Pharmaceuticals Inc ADIL Corporate Update Timing not specified n/a Low
Alzamend Neuro Inc ALZN Topline Data March 2026 n/a Low
Aspire Biopharma Holdings Inc ASBP Corporate Update July 2025 n/a Low
Atara Biotherapeutics Inc ATRA FDA Meeting January 2025 n/a Low
Genprex Inc GNPX IND Filing Nov 2021 AVA6000 Low
Genprex Inc GNPX Enrollment Update Dec 2020 COVID-19 Low
Kiora Pharmaceuticals Inc KPRX Data Readout Timing not specified n/a Low
Processa Pharmaceuticals Inc PCSA Data Readout Timing not specified n/a Low
Quoin Pharmaceuticals Ltd ADR QNRX IND Filing Timing not specified n/a Low

Get the weekly biotech catalyst watchlist.

Subscribe